Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 49 min ago
PreprintCC BYmedRxiv

Serum Vitamin D Levels do not Affect Susceptibility to EBV Infection. A Mendelian Randomization Study.

  • J. Stanley1
  • F. Hamilton
  • G. Davey Smith
  1. 1North Bristol NHS Trust
Read full textPDFDOICite

Abstract

Introduction: Epstein-Barr virus (EBV) infection and low serum 25-hydroxyvitamin D (25OHD) levels are strongly associated with multiple sclerosis (MS). We investigated whether genetically proxied serum vitamin D levels are causally linked to EBV infection, assessed by serology and detectable EBV DNA, using Mendelian randomisation (MR). Methods: We conducted two-sample cis-MR using genetic instruments associated with serum 25OHD concentrations, restricted to variants near genes implicated in vitamin D metabolism. Outcomes included EBV seropositivity, antibody responses to four EBV antigens, detectable EBV DNA in blood and saliva, and MS case status as a positive control. Results: Genetically proxied vitamin D levels had no clear effect on EBV seropositivity (odds ratio per standard deviation (SD) increase in rank-based inverse-normal transformation (RINT) 25OHD: 1.76, 95% confidence interval [CI] 0.83-3.73) or antibody responses to EBV antigens. No significant associations were observed with detectable EBV DNA in blood (beta 0.02, 95% CI -0.004 to 0.04) or saliva (beta 0.02, 95% CI -0.23 to 0.26). In contrast, genetically proxied vitamin D levels were associated with reduced MS risk (odds ratio per SD increase in RINT 25OHD 0.67, 95% CI 0.54-0.84). Discussion: We found no clear evidence that genetically proxied vitamin D levels causally influence EBV serological responses or detectable EBV DNA in blood or saliva. The protective association with MS supports previous genetic evidence. These findings suggest that vitamin D and EBV may influence MS risk through distinct pathways, although effects specific to early-life vitamin D exposure remain possible.

Related

  1. Dual-Axis Pattern of Peripheral Immunity in Myasthenia Gravis Susceptibility: A Prospective Cohort Study and Mendelian Randomization Analysis
    Jiang Lei, Hao Huang, Jiaxin Chen +2
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Telomere length as a systemic aging-related susceptibility marker for trigeminal neuralgia: Genetic evidence from mendelian randomization
    Temitope M. Adegbenro, Jun He, Renato Polimanti +2
    Molecular PainPeer-reviewedCC BYFull textGeneral medicineDOAJ
  3. Abdominal Adiposity and Lacunar Stroke: A Mendelian Randomization Mediation Study
    M. Guo, L. Cong, Z. Liu
    medRxivPreprintAll rights reservedFull textCardiovascular medicinemedRxiv
  4. Genetically Proxied SGLT2 Inhibition and Risk of Epilepsy: A Mediation Mendelian Randomization Study of Circulating Metabolites
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Stroke and brain white/gray matter alterations : A Mendelian randomization investigation
    Xiaoyong Wu, Longtao Yang, Weijia Xu +1
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{stanley2026serum,
  title = {{Serum Vitamin D Levels do not Affect Susceptibility to EBV Infection. A Mendelian Randomization Study.}},
  author = {J. Stanley and F. Hamilton and G. Davey Smith},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.29.26366817},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.29.26366817v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Serum Vitamin D Levels do not Affect Susceptibility to EBV Infection. A Mendelian Randomization Study.
AU  - J. Stanley
AU  - F. Hamilton
AU  - G. Davey Smith
PY  - 2026
DA  - 2026/10/29
PB  - medRxiv
DO  - 10.64898/2026.10.29.26366817
UR  - https://www.medrxiv.org/content/10.64898/2026.10.29.26366817v1
AB  - Introduction: Epstein-Barr virus (EBV) infection and low serum 25-hydroxyvitamin D (25OHD) levels are strongly associated with multiple sclerosis (MS). We investigated whether genetically proxied serum vitamin D levels are causally linked to EBV infection, assessed by serology and detectable EBV DNA, using Mendelian randomisation (MR). Methods: We conducted two-sample cis-MR using genetic instruments associated with serum 25OHD concentrations, restricted to variants near genes implicated in vitamin D metabolism. Outcomes included EBV seropositivity, antibody responses to four EBV antigens, detectable EBV DNA in blood and saliva, and MS case status as a positive control. Results: Genetically proxied vitamin D levels had no clear effect on EBV seropositivity (odds ratio per standard deviation (SD) increase in rank-based inverse-normal transformation (RINT) 25OHD: 1.76, 95% confidence interval [CI] 0.83-3.73) or antibody responses to EBV antigens. No significant associations were observed with detectable EBV DNA in blood (beta 0.02, 95% CI -0.004 to 0.04) or saliva (beta 0.02, 95% CI -0.23 to 0.26). In contrast, genetically proxied vitamin D levels were associated with reduced MS risk (odds ratio per SD increase in RINT 25OHD 0.67, 95% CI 0.54-0.84). Discussion: We found no clear evidence that genetically proxied vitamin D levels causally influence EBV serological responses or detectable EBV DNA in blood or saliva. The protective association with MS supports previous genetic evidence. These findings suggest that vitamin D and EBV may influence MS risk through distinct pathways, although effects specific to early-life vitamin D exposure remain possible.
ER  -